Skip to Main Content

Paper Details

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease.
Mol Psychiatry
40
2022
AD, Alzheimer's disease, Astrocyte, Astrocytes, CSF, CSF GFAP, CSF YKL-40, GFAP, YKL-, YKL-40, [F]AZD4694, [F]MK-6240, astrocyte, astrogliosis, brain amyloid, chitinase-3-like protein 1, cognitive impairment, glial fibrillary acidic protein, hippocampal atrophy, patients, tau
Author NameAffiliation
Yi-Ting WangMcGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre integre universitaire de sante et de services sociaux (CIUSSS) de l'Ouest-de-l'Ile-de-Montreal Department of Neurology and Neurosurgery, McGill University
Yi-Ting WangMcGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre integre universitaire de sante et de services sociaux (CIUSSS) de l'Ouest-de-l'Ile-de-Montreal Department of Neurology and Neurosurgery, McGill University
Gleb BezginMcGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre integre universitaire de sante et de services sociaux (CIUSSS) de l'Ouest-de-l'Ile-de-Montreal Department of Neurology and Neurosurgery, McGill University
  • 1 - 3

Datasets

Release 1.2